Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	24.25B +65.4%
Revenue (ttm)	1.25B -10.8%
Net Income	57.48M +9.9%
EPS	0.06 +2.3%
Shares Out	966.49M
PE Ratio	421.90
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,137,899
Average Volume	19,565,628
Open	26.50
Previous Close	25.09
Day's Range	24.80 - 26.50
52-Week Range	14.66 - 30.20
Beta	0.45
RSI	38.50
Earnings Date	Apr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2024, SHE:000766's revenue was 1.32 billion, a decrease of -10.23% compared to the previous year's 1.47 billion. Earnings were 56.44 million, an increase of 28.46%.